Zimmer Biomet Holdings Inc (ZBH)
118.46
-1.10
(-0.92%)
USD |
NYSE |
May 02, 16:00
118.46
0.00 (0.00%)
After-Hours: 16:00
Zimmer Biomet Holdings Enterprise Value: 30.02B for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | 30.02B |
April 30, 2024 | 30.17B |
April 29, 2024 | 30.47B |
April 26, 2024 | 29.98B |
April 25, 2024 | 30.06B |
April 24, 2024 | 30.35B |
April 23, 2024 | 30.43B |
April 22, 2024 | 30.27B |
April 19, 2024 | 30.00B |
April 18, 2024 | 29.98B |
April 17, 2024 | 30.38B |
April 16, 2024 | 30.54B |
April 15, 2024 | 30.93B |
April 12, 2024 | 31.03B |
April 11, 2024 | 31.66B |
April 10, 2024 | 31.70B |
April 09, 2024 | 32.04B |
April 08, 2024 | 31.49B |
April 05, 2024 | 31.62B |
April 04, 2024 | 31.67B |
April 03, 2024 | 32.17B |
April 02, 2024 | 31.85B |
April 01, 2024 | 32.11B |
March 28, 2024 | 32.57B |
March 27, 2024 | 32.70B |
Date | Value |
---|---|
March 26, 2024 | 31.73B |
March 25, 2024 | 31.74B |
March 22, 2024 | 31.59B |
March 21, 2024 | 31.56B |
March 20, 2024 | 31.45B |
March 19, 2024 | 31.48B |
March 18, 2024 | 31.34B |
March 15, 2024 | 31.17B |
March 14, 2024 | 31.29B |
March 13, 2024 | 31.47B |
March 12, 2024 | 31.80B |
March 11, 2024 | 31.76B |
March 08, 2024 | 31.50B |
March 07, 2024 | 31.62B |
March 06, 2024 | 31.31B |
March 05, 2024 | 31.09B |
March 04, 2024 | 31.24B |
March 01, 2024 | 30.94B |
February 29, 2024 | 31.01B |
February 28, 2024 | 30.96B |
February 27, 2024 | 31.42B |
February 26, 2024 | 31.53B |
February 23, 2024 | 32.00B |
February 22, 2024 | 31.87B |
February 21, 2024 | 31.83B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.77B
Minimum
Mar 18 2020
43.24B
Maximum
Apr 29 2021
33.51B
Average
32.66B
Median
May 26 2020
Enterprise Value Benchmarks
Stryker Corp | 135.46B |
Edwards Lifesciences Corp | 49.77B |
Align Technology Inc | 20.52B |
Globus Medical Inc | 6.726B |
Paragon 28 Inc | 851.57M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 419.20M |
Revenue (Quarterly) | 1.940B |
Total Expenses (Quarterly) | 1.519B |
EPS Diluted (Quarterly) | 2.01 |
Gross Profit Margin (Quarterly) | 72.23% |
Profit Margin (Quarterly) | 21.61% |
Earnings Yield | 4.13% |
Operating Earnings Yield | 5.84% |
Normalized Earnings Yield | 4.674 |